TORONTO, ONTARIO--(Marketwire -09/06/12)- Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that ...

From Jan 1, 2015, HealthTrust members will have access to AngioDynamics' entire PICC portfolio, including its thromboresistant BioFlo PICC product line and Celerity tip location system. The new ...

AngioDynamics, Inc. ANGO recently announced the completion of the sale of its PICC and Midline product portfolios to Spectrum Vascular for $45 million in cash. AngioDynamics' PICC, Midline, and tip ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

AngioDynamics has announced it has received FDA clearance for a new peripherally inserted central catheter, according to a news release. The company’s BioFlo peripherally inserted central catheters ...

Angiodynamics Inc. has filed a lawsuit against C.R. Bard Inc., claiming the Murray Hill, N.J.-based company has violated antitrust laws with its catheter tip locators. The lawsuit was filed in the U.S ...

ALBANY, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters (“PICCs”), violating federal ...

AngioDynamics (Albany, New York) said it has received clearance for its BioFlo Port with Endexo technology, a device designed to reduce the accumulation of cather-related thrombus on, and in, the port ...

Good day and welcome to the AngioDynamics 2016 Fiscal Year Fourth Quarter Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Mr. Jim Polson.

Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected to add approximately $30 million of revenue, on ...